Provision Holding Announces Executive Leadership Changes to Position Company for Future Growth
Sep 14, 2017 11:30 am UTC| Business
Retail Industry Veteran Mark Leonard Appointed President and Chief Executive Officer; Curt Thornton Assumes Role of Board Chairman and Chief Operating Officer Provision’s Board Will Expand to Five Directors from Three ...
FONAR Announces Fiscal 2017 Year-End Earnings
Sep 14, 2017 11:30 am UTC| Business
23% Increase of Fiscal 2017 Diluted Net Income per Common Share available to Common Shareholders to $2.92, versus prior year26% Increase of Fiscal 2017 Net Income to $23.7 million, versus prior year33% Increase of Fiscal...
Sep 14, 2017 11:30 am UTC| Business
LEESBURG, Va., Sept. 14, 2017 -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body...
ETC Selects Eventus Systems for Its State of the Art Trading Risk Management Platform
Sep 14, 2017 11:30 am UTC| Business
AUSTIN, Texas, Sept. 14, 2017 -- Eventus Systems, Inc. (“Eventus”), a provider of innovative regtech software solutions announced that Electronic Transaction Clearing, Inc. (“ETC”) is now a client of its Validus risk...
$1.4 Trillion Worldwide OEM Electronics Assembly Market 2017
Sep 14, 2017 11:24 am UTC| Business
Dublin, Sept. 14, 2017 -- The "The Worldwide OEM Electronics Assembly Market - 2017 Edition" report has been added to Research and Markets' offering. The worldwide electronics assembly market is...
Sep 14, 2017 11:22 am UTC| Business
RICHLAND, Wash., Sept. 14, 2017 -- Advanced Medical Isotope Corporation ("AMI") (OTC PINK:ADMD), a late stage radiation oncology focused medical device company’s business plan is to generate initial revenues from animal...
Successful Phase III trial for ALK’s tree allergy SLIT-tablet
Sep 14, 2017 11:15 am UTC| Business
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the successful outcome of a pivotal Phase III clinical trial of its tree allergy sublingual immunotherapy (SLIT) tablet, with the trial meeting its primary...